Risk Factors for Human Papillomavirus Infection and Abnormal Cervical Cytology Among Perinatally Human Immunodeficiency Virus-Infected and Uninfected Asian Youth
Annette H Sohn,Stephen J Kerr,Rawiwan Hansudewechakul,Sivaporn Gatechompol,Kulkanya Chokephaibulkit,Hanh Le Dung Dang,Dan Ngoc Hanh Tran,Jullapong Achalapong,Nipat Teeratakulpisarn,Amphan Chalermchockcharoenkit,Manopchai Thamkhantho,Tippawan Pankam,Thida Singtoroj,Wichai Termrungruanglert,Surasith Chaithongwongwatthana,Nittaya Phanuphak,Sivaporn Gatechompol,Stephen Kerr,Chavalun Ruengpanyathip,Kulkanya Chokephaibulkit,Manopchai Thamkhantho,Amphan Chalermchockcharoenkit,Sirintip Sricharoenchai,Rawiwan Hansudewechakul,Jullapong Achalapong,Vanichaya Wanchaitanawong,Dang Le Dunh Hanh,Dang Ngoc Yen Dung,Tran Dang Thang,Dan Ngoc Hanh Tran,Khanh Huu Truong,Surasith Chaithongwongwatthana,Wichai Termrungruanglert,Surang Triratanachat,Sunee Sirivichayakul,Joel M Palefsky,Nittaya Phanuphak,Nipat Teeratakulpisarn,Tippawan Pankam,Annette Sohn,Jeremy Ross,Thida Singtoroj,Waropart Pongchaisit,Kamonrat Kosaphan,
DOI: https://doi.org/10.1093/cid/ciy144
IF: 20.999
2018-03-30
Clinical Infectious Diseases
Abstract:Abstract Background Infection with high-risk human papillomavirus (HR-HPV) may be higher in perinatally human immunodeficiency virus (HIV)–infected (PHIV) than HIV-uninfected (HU) adolescents because of long-standing immune deficiency. Methods PHIV and HU females aged 12–24 years in Thailand and Vietnam were matched by age group and lifetime sexual partners. At enrollment, blood, cervical, vaginal, anal, and oral samples were obtained for HPV-related testing. The Wilcoxon and Fisher exact tests were used for univariate and logistic regression for multivariate analyses. Results Ninety-three PHIV and 99 HU adolescents (median age 19 [18–20] years) were enrolled (June 2013–July 2015). Among PHIV, 94% were currently receiving antiretroviral therapy, median CD4 count was 593 (392–808) cells/mm3, and 62% had a viral load <40 copies/mL. Across anogenital compartments, PHIV had higher rates of any HPV detected (80% vs 60%; P = .003) and any HR-HPV (60% vs 43%, P = .02). Higher proportions of PHIV had abnormal Pap smears (eg, atypical squamous cells of unknown significance [ASC-US], 12% vs 14%; low-grade squamous intraepithelial neoplastic lesions, 19% vs 1%). After adjusting for ever being pregnant and asymptomatic sexually transmitted infections (STI) at enrollment, PHIV were more likely to have HR-HPV than HU (odds ratio, 2.02; 95% confidence interval, 1.09–3.77; P = .03). Conclusions Perinatal HIV infection was associated with a higher risk of HR-HPV and abnormal cervical cytology. Our results underscore the need for HPV vaccination for PHIV adolescents and for prevention and screening programs for HPV and other STIs.
immunology,infectious diseases,microbiology